Newsbenzinga
Elutia Sheds Legacy Business to Chase $1.5 Billion Market Opportunity
· Published
Article summary
Elutia (NASDAQ:ELUT) sells SimpliDerm to Cellution Biologics for up to $11M to boost its balance sheet ahead of the NXT-41x launch.
An excerpt from the original article.
Comments —
Loading comments…